Douglas S. Ingram, President & CEO at Sarepta Therapeutics, Inc. (SRPT), bought 33,390 shares at $120.26 ($4.0M) on 2018-10-30, disclosed to the SEC on 2018-10-30.
Recurring purchase ($4.0M) by President & CEO following this insider's established cadence. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.26 | 13,561 | $1.6M | 40.6% |
| 2 | $120.26 | 13,561 | $1.6M | 40.6% |
| 3 | $120.94 | 3,134 | $379K | 9.4% |
| 4 | $120.94 | 3,134 | $379K | 9.4% |
| Total | $120.39 avg | 33,390 | $4.0M | 100% |
| Filing → |
| RLAY | BUY | 2020-07-21 | $500K | — | Filing → |
| SRPT | BUY | 2019-08-12 | $4.0M | — | Filing → |
| SRPT | BUY | 2018-08-16 | $2.0M | — | Filing → |